Foley Hoag Partner Jeff Quillen will speak on the panel “Investing in Biotech Breakthroughs: A VC Outlook” at the LSX USA Congress. Despite a complex funding landscape, VC’s remain bullish on the potential of biotech innovation. This panel of leading investors will explore the 2025 funding landscape so far, the outlook for the remainder of the year, diving into the forces shaping the industry and the cutting-edge therapies of tomorrow. This candid discussion will highlight where capital is flowing, how companies are adapting, and what the future holds for biotech breakthroughs.
Key topics include:
Overview of the key biotech investment trends so far in 2025
What are the most critical factors—economic, regulatory, technological—that will impact biotech over the next 12-24 months and beyond? How can companies prepare for these shifts?
How are investors balancing investments in early-stage versus late-stage biotech companies?
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
